DRKS00023792
Recruiting
未知
Anatomical Resection of liver MetAstases iN patIents with RAS-mutated colorectal cancer - ARMANI
Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie Universitätsklinikum Carl Gustav Carus an der Technischen Universität DresdenAnstalt des öffentlichen Rechts des Freistaates Sachsen0 sites240 target enrollmentJanuary 4, 2021
ConditionsColorectal liver metastases
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Colorectal liver metastases
- Sponsor
- Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie Universitätsklinikum Carl Gustav Carus an der Technischen Universität DresdenAnstalt des öffentlichen Rechts des Freistaates Sachsen
- Enrollment
- 240
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Colorectal cancer with RAS mutation (KRAS or NRAS)
- •Colorectal liver metastases (single or multiple)
- •Planned R0 resection of liver metastases (and primary tumor, if present)
- •Anatomical and non\-anatomical liver resection technically feasible
- •Male and female patients, age \= 18 years
- •Written informed consent
Exclusion Criteria
- •Extrahepatic metastases
- •Planned staged liver resection (e.g. two\-stage hepatectomy)
- •Diagnosis of another cancer \< 5 years prior to randomization Exceptions: curatively treated in situ cervical cancer, curatively resected non\-melanoma skin cancer
- •Expected lack of compliance
- •Addiction or other illnesses which do not allow the person concerned to assess the nature and extent of the clinical trial and its possible consequences
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Surgery for colorectal liver metastases in the setting of extrahepatic disease in the era of multidisciplinary approachesExtrahepatic disease from colorectal cancerJPRN-UMIN000029660Cancer Institute Hospital of the Japanese Foundation for Cancer Research581
Completed
Phase 1
Hepatic Resection for Colorectal Liver Metastases following Panitumumab(Vectibix) with Chemotherapy Cohort studynresectable colorectalcancer with hepatic metastasesJPRN-UMIN000017397Gastroenterological Surgery1, Hokkaido University Graduate school of medicine100
Completed
Not Applicable
MR-guided biopsy of liver metastases in patients with suspected pancreatic cancerNL-OMON47537Radboud Universitair Medisch Centrum20
Not yet recruiting
Not Applicable
Anatomical Resection VS. Nonanatomical Resection for Colorectal Liver Metastases With Gene Mutation or Right-sidednessColorectal CarcinomaLiver MetastasesNCT05881746Fudan University176
Completed
Not Applicable
Assessment of the Safety and Efficacy of Intra-Arterial Liver Isolation Chemotherapy Using an Implantable Vascular Access System1. Secondary hepatic metastases from colorectal cancer2. Hepatocellular carcinoma1. Secondary hepatic metastases from colorectal cancer2. Hepatocellular carcinomaCancer - LiverACTRN12611001273976Dr Rodney Lane10